Verona Pharma's total assets for Q2 2025 were $572.87M, an increase of 8.92% from the previous quarter. VRNA total liabilities were $294.60M for the fiscal quarter, a -1.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.